[{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Curcumin","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Royal DSM","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NETHERLANDS","productType":"Controlled Substance","year":"2024","type":"Inapplicable","leadProduct":"Cannabidiol","moa":"Cannabinoid CB1 receptor","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"6","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Controlled Substance","year":"2022","type":"Inapplicable","leadProduct":"Cannabinol","moa":"cannabinol derivatives","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Royal DSM","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NETHERLANDS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2024","type":"Inapplicable","leadProduct":"Ascorbic Acid","moa":"Collagen (CO)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nordic Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"FRANCE","productType":"Dietary Supplement","year":"2015","type":"Inapplicable","leadProduct":"Fish Oil","moa":"Diacylglycerol O-acyltransferase 2; Prostaglandin G\/H synthase 2; Free fatty acid receptor 4; Voltage gated L-type calcium channel; Sodium channel protein; Free radicals; Nuclear factor NF-kappa-B; Sterol regulatory element-binding protein 1; Peroxisome proliferator-activated receptor alpha; Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor delta","graph1":"Undisclosed","graph2":"Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"8","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Biodroga Inc. | University of Guelph","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CANADA","productType":"Dietary Supplement","year":"2012","type":"Inapplicable","leadProduct":"Fish Oil","moa":"Diacylglycerol O-acyltransferase 2; Prostaglandin G\/H synthase 2; Free fatty acid receptor 4; Voltage gated L-type calcium channel; Sodium channel protein; Free radicals; Nuclear factor NF-kappa-B; Sterol regulatory element-binding protein 1; Peroxisome proliferator-activated receptor alpha; Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor delta","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Biodroga Inc. | University of Guelph","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Biodroga Inc. | University of Guelph"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2017","type":"Inapplicable","leadProduct":"Magnesium","moa":"GABA-B receptor","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"CANADA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"CAS 492-27-3","moa":"Glutamate receptor ionotropic, NMDA 1; Glutamate receptor ionotropic, NMDA 2B; Glutamate receptor ionotropic, NMDA 2A; Aryl hydrocarbon receptor; G-protein coupled receptor 35","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase II\/ Phase III","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Cream","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"9","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"U.S.A","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"LALLEMAND HEALTH SOLUTIONS","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"CANADA","productType":"Probiotic","year":"2019","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"8","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"ISRAEL","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"NF-kappa-B inhibitor alpha","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nordic Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"FRANCE","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Omega-3-Acid Ethyl Esters 90","moa":"Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor alpha; Sterol regulatory element-binding protein 1","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"BASF","pharmaFlowCategory":"DU","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","country":"NORWAY","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2016","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hepatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Kirin Holdings","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Cognizin","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Alpha-GPC","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"CANADA","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Arrabina P Prebiotic","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"IRELAND","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Bacillus Subtilis ATCC 122264","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Bioplete","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"BELGIUM","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Enzyme","year":"2025","type":"Inapplicable","leadProduct":"Digestive Enzyme Blend","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"8","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"CANADA","productType":"Dietary Supplement","year":"2010","type":"Inapplicable","leadProduct":"Femmed Breast Health Formula","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"Nutrasource \/ Undisclosed"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2016","type":"Inapplicable","leadProduct":"Immunoglobulin Y","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I\/ Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"7","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Inulinase","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Bonafide Health","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"JDS-HF","moa":"Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"KH-1","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"SOUTH KOREA","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Korean Red Ginseng Extract","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2018","type":"Inapplicable","leadProduct":"Multivitamin","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Elysium Health","pharmaFlowCategory":"DU","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","country":"U.S.A","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"NRPT","moa":"Undisclosed","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hepatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2019","type":"Inapplicable","leadProduct":"Nutriterra","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I\/ Phase II","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"7","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Pharmalink International Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"PCSO-524","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Pharmalink International Ltd.","highestDevelopmentStatusID":"6","companyTruncated":"Nutrasource \/ Pharmalink International Ltd."},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Potato Starch","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"11","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nordic Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Pro-Omega LDL","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase IV","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"11","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"U.S.A","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"TPG1","moa":"Undisclosed","graph1":"Immunology","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Xylooligosaccacharide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Powder","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"},{"orgOrder":0,"company":"Nutrasource","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"HONG KONG","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nutrasource","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrasource \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Nutrasource \/ Nutrasource"}]
Find Clinical Drug Pipeline Developments & Deals by Nutrasource
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
